Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients-Reference-Cited by-同舟云学术

Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients

Published:2019-12-12 Issue:2 Volume:104 Page:138-144
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Antonioli Elisabetta¹^ORCID,Nozzoli Chiara²,Buda Gabriele³,Staderini Michela¹,Boncompagni Riccardo²,Martini Francesca³^ORCID,Petrini Mario³,Bosi Alberto¹,Saccardi Riccardo²

Affiliation:

1. Haematology Unit Careggi University Hospital Florence Italy

2. Cellular Therapy and Transfusion Medicine Unit Careggi University Hospital Florence Italy

3. Department of Clinical and Experimental Medicine U.O. Hematology University of Pisa Pisa Italy

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13357

Reference22 articles.

1. Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

2. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

3. Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

4. Autologous stem cell transplant for multiple myeloma patients 70 years or older

5. Evaluation of the Feasibility and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphatidylinositol 3-kinase signaling inhibitors for treatment of multiple myeloma: From small molecules to microRNAs;Journal of Oncology Pharmacy Practice;2021-10-06

2. Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple;Hematological Oncology;2020-04-20

3. Dexamethasone/melphalan;Reactions Weekly;2020-02